Ghost Tree Capital’s Insys Therapeutics INSY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
– Sell
-200,000
Closed -$4.22M – 87
2014
Q4
$4.22M Buy
+200,000
New +$3.95M 2.02% 21

Other funds holding INSY

Ghost Tree Capital's INSY Position: Q1 2015 in Review

Ghost Tree Capital sold out of Insys Therapeutics (INSY) in Q1 2015, closing a stake of 200,000 shares — an estimated $4.22M sold.

Ghost Tree Capital first reported a position in INSY in Q4 2014 and held it in 1 quarter. The position peaked at $4.22M in Q4 2014. 133 funds tracked by Wall St. Rank hold INSY as of Q1 2015.

  • Ghost Tree Capital reported no remaining Insys Therapeutics position as of Q1 2015 after selling out during the quarter.
  • Ghost Tree Capital sold 200,000 Insys Therapeutics shares in Q1 2015, an estimated $4.22M.
  • Ghost Tree Capital first reported a position in Insys Therapeutics in Q4 2014 and held it in 1 quarter.
  • Ghost Tree Capital's Insys Therapeutics position peaked at $4.22M in Q4 2014.
  • 133 funds tracked by Wall St. Rank held Insys Therapeutics as of Q1 2015.

Based on Ghost Tree Capital's 13F filing for Q1 2015, filed 15 May 2015.